PT Itama Ranoraya Tbk (ISX:IRRA) ROCE % : 7.44% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is PT Itama Ranoraya Tbk ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Itama Ranoraya Tbk's annualized ROCE % for the quarter that ended in Mar. 2024 was 7.44%.

PT Itama Ranoraya Tbk ROCE % Historical Data

The historical data trend for PT Itama Ranoraya Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Itama Ranoraya Tbk ROCE % Chart

PT Itama Ranoraya Tbk Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

29.41

32.87

40.13

14.45

4.76

PT Itama Ranoraya Tbk Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															10.46	8.56	-	-5.63	7.44

PT Itama Ranoraya Tbk ROCE % Calculation

PT Itama Ranoraya Tbk's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	22531.607	/	( ( (733925.274 - 248796.364)	+	(1058886.244 - 597877.582) )	/ 2 )
	=	22531.607	/	( (485128.91	+	461008.662)	/ 2 )
	=	22531.607	/	473068.786
	=	4.76 %

PT Itama Ranoraya Tbk's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	34457.92	/	( ( (1058886.244 - 597877.582)	+	(1071781.104 - 606891.797) )	/ 2 )
	=	34457.92	/	( ( 461008.662	+	464889.307 )	/ 2 )
	=	34457.92	/	462948.9845
	=	7.44 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

PT Itama Ranoraya Tbk (ISX:IRRA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PT Itama Ranoraya Tbk ROCE % Related Terms

Thank you for viewing the detailed overview of PT Itama Ranoraya Tbk's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Itama Ranoraya Tbk (ISX:IRRA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Itama Ranoraya Tbk (ISX:IRRA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

MT. Haryono Square Lantai 1 Unit 101, Jl. Otto Iskandardinata Raya No. 390, No. 390 Jakarta Timur, Jakarta, IDN, 13330

Website

https://www.itama.co.id

PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. The key revenue generating segments of the company are Sterile Non-Electromedical Medical Equipment and In Vitro Diagnostic product.

PT Itama Ranoraya Tbk (ISX:IRRA) Headlines

No Headlines